Pulmonary surfactant is thought to be internalized and processed for reuse by alveolar Type I1 cells. In the present study we followed the intemalization and intracellular trafficking of putified surfactant protein A (SPA) by primary cultures of alveolar Type II cells. Intemalization of native rat SPA was compared with that of recombinant rat and human SPA isolated from a patient with alveolar proteinosis. All SPA species were conjugated with colloidal gold for visualization by electron microscopy. The gold conjugates were biologically active, as demonstrated by inhibition of phospholipid secretion from alveolar Type II cells. The SP A-gold conjugates were intemalized to lamellar bodies (LB) via the endosomal system, which included both electronlucent and -dense multivesicular bodies. Labeling of LB was time dependent, and after 7 hr 30-&% of these organelles were labeled. Alkylation of SPA greatly reduced internalization, as did an excess of non-conjugated SPA. No qualitative differences in uptake were observed with the three forms
Introduction
Surfactant is a heterogeneous mixture of lipids and proteins secreted by alveolar Type 11 cells. It functions to lower surface tension and to stabilize alveoli at low lung volumes (1J). Studies of exogenous surfactant in vivo indicate that surfactant lipids and associated proteins are internalized from the alveolar lumen into Type I1 cells and recycled (3-7). The magnitude of uptake of surfactant into Type I1 cells in adult animals has been estimated to range from 25-85 % of the extracellular pool within 24 hr (8). The protein components of surfactant may be important in targeting extracellular surfactant into Type I1 cells. Surfactant-associated protein A (SP- of SPA. The percent of labeled LB was similar (3O4O0/o) after 7 hr of internalization with the three species of SPA. The recombinant SPA produced using a baculovirus vector lacked hydroxyproline and had an altered oligosaccharide, but these features did not affect its internalization or the rate of LB labeling. Internalization of the gold-conjugated SPA and endocytosis of the fluid-phase marker Lucifer Yellow were related to the shape of Type II cells. Both uptake of SPA, which is receptor mediated, and fluid-phase endocytosis were found to be less active in the flattened than in the rounded cells. Therefore, cell shape and hence cytoskdetal organization may play an important role in SPA recyding. However, it is possible that both morphology and decreased endocytosis are independent manifestations related to the A) binds with high affinity to receptors on isolated Type I1 cells and is further internalized with no apparent degradation (9-11). SP-A also enhances uptake of phospholipids into Type I1 cells (12) and inhibits secretion of surfactant phospholipids in vitro (13) (14) (15) . These functions suggest that SP-A may play a role in surfactant homeostasis.
Several studies have addressed the binding of SP-A to cell surface receptors and the subsequent intracellular trafficking of the protein. Young et al. (7) demonstrated cell uptake and processing of SP-A by rat lung. After internalization, the radiolabeled SP-A accumulated in a time-dependent manner in the lamellar body (LB)-enriched fraction. Kalina and Socher (16) found that rat surfactant labeled by gold conjugation was internalized via coated vesicles and the endosomal system to LB of isolated rat alveolar Type I1 cells. However, these results were obtained with whole surfactant and not purified proteins. Although SP-A is a major component of surfactant, other surfactant-associated proteins could have contributed to the observed internalization. Using purified rat SP-A, Ryan et al. (11) have demonstrated that binding of SP-A to isolated Type I1 cells is a dose-dependent and saturable process. With the biotinyl ligand-avidin-gold technique, these authors demonstrated intemalization of biotinyl-SP-A-gold via the endosomal system into rat alveolar Type I1 cells. However, they were unable to detect the gold label in lamellar bodies.
In the present study we followed the internalization of gold labeled SP-A into isolated rat alveolar Type I1 cells in vitro. The purpose of these experiments was to document that SP-A reached the lamellar body compartment in vitro, to measure the time course for this translocation, and to determine if there were differences between native rat and recombinant rat SP-A, which have known structural differences. Human SP-A was also used to evaluate intracellular trafficking, which may differ from that of native rat SP-A. Internalization of the gold-conjugated SP-A was related to the shape of Type I1 cells in vitro. Kalina and Socher (17) had microscopically observed that endocytosis of Lucifer Yellow by alveolar Type I1 cells was more prominent in rounded cells than in flattened cells.
The present results indicate that the shape of the cells (rounded vs flattened) is a factor in both fluid-phase endocytosis and receptormediated uptake of SP-A. Both processes were found to be less active in the flattened than in the rounded cells.
Materials and Methods
Cells. Alveolar Type I1 cells were isolated from adult Sprague-Dawley male rats by tissue dissociation with elastase and purification on metrizamide density gradients (18). Isolated Type I1 cells were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% (vlv) fetal bovine serum (FBS). Cells were plated at a density of 2 x lo6 cells per 35-mm tissue culture dish and were grown at 37'C in a humidified incubator in a 10% CO2 atmosphere. In some experiments cells were grown on poly-D-lysine (PDL); (Sigma; St Louis, MO)-coated plates because under these conditions they maintain more of a cuboidal/rounded shape for the first 2 days of culture. The plates were coated with PDL (100 pglml) by adding 1 ml per 35-mm tissue culture dish at room temperature and waiting for S min. The excess PDL was removed by washing with sterile H20, and the culture dishes were used immediately. For light microscopy, cells were placed on glass coverslips in tissue culture dishes. In some experiments the glass coverslips were also coated with PDL. Coverslips were immersed in PDL (100 pglml) and washed in sterile H20 before use.
Labeling of Alveolar Type II Cells with Lucifer Yellow. Lucifer Yellow is a fluorescent fluid-phase marker which is taken up into endosomes and lysosomes (19). Lucifer Yellow 6 mglml (Sigma) in DMEM-FBS was added to cultured Type I1 cells and incubated for different time intervals. For light microscopy, cells were cultured on coverslips with and without a coating of PDL. Cells were then washed in PBS, fixed in 3% paraformaldehyde in PBS for 10 min. mounted in g1ycerol:PBS (9:1), and observed in an Olympus fluorescence microscope equipped with an epifluorescence illuminator and appropriate barrier filters. Quantitative estimation of endocytosed Lucifer Yellow was performed on cells that were grown on uncoated (plastic) and PDLcoated 35-mm culture dishes. Quantitative analysis of the Lucifer Yellow was performed after extraction of the fluorescent dye from the cells as described by Swanson et al. (19) . The fluorescence of the dye was expressed as ng Lucifer Yellow per mg protein. estimated according to Lowry et al. (20) . or per pg DNA (21).
Prepatation of SPA. Purified SP-A from three sources was used in the present study. Rat SP-A was isolated from rats 4 weeks after intratracheal instillation of silica and was purified as previously described (10,14.22) . Human SP-A was isolated and purified from lavages of patients with alveolar proteinosis in a similar fashion to rat SP-A, which required sequential delipidation, mannose-sepharose affinity chromatography, and gel filtration on Biogel A5M. Wild-type recombinant rat SP-A was expressed in a baculovi-IUS expression system as described (23, 24) . This recombinant SP-A is glycosylated in a simple, mannose-rich manner, is devoid of hydroxyproline, and forms incomplete oligomers but functions as an inhibitor of surfactant secretion from Type I1 cells. Alkylated native rat SP-A was prepared according to the method described by Kuroki et al. (22) .
Preparation of Gold-conjugated Proteins. Colloidal gold suspensions of 8-and 15-nm diameter particles were prepared with tannic acid according to the method of Slot and Gueze (25) . The minimum amount of SP-A (rat, human, recombinant, or alkylated) required to stabilize the gold at pH 6.0 was determined by the standard NaCl precipitation assay (26). SP-A-gold complexes (8-and 15-nm gold particles) were prepared according to Roth (27) . Bovine serum albumin (BSA) was also complexed with gold (8 and 15 nm) according to Roth (27) .
Internalization of Human SPA: Light Microscopy. Human SP-A was used to examine the internalization of unconjugated SP-A into rat alveolar Type I1 cells by light microscopy. Human SP-A (1-5 pg/ml DMEM-FBS) was added to alveolar Type I1 cells cultured on PDLcoated and uncoated coverslips and incubated at 37'C for 1-7 hr. The cells were then washed in PBS and fixed in 3% paraformaldehyde for 15 min. SP-A was localized in the cells by immunostaining with monoclonal anti-human SP-A (PElo). which does not recognize rat SP-A (28). The immunostaining was performed as described (29) . Briefly, cells were permeabilited for 5 min with 0.2% Triton X-lOO-PBS, treated for 30 min with donkey IgG (100 pg/ml), and reacted overnight at 4°C with the primary antibody. The cells were then washed in PBS and incubated with donkey anti-mouse rhodamine (1:150) (Jackson Labs; West Grove, PA) for 1 hr, washed, and the coverslips were mounted in glycerol-PBS.
Internalization Experiments. Most experiments were conducted with isolated Type I1 cells cultured in 35-mm culture dishes for 20-22 hr. After the cells adhered, they were washed and the medium was replaced with 1 ml fresh DMEM + 10% FBS. The cells were then incubated for an additional 30 min at 37% before the gold probes were added. The various SP-Agold probes (8-nm or 15-nm gold particles) were standardized according to the absorbance at 520 nm of the gold probes (A>20nm = 4.5) and 50 p1 of the gold probe was added to the above DMEM-FBS medium. The dishes were incubated at 37°C for periods ranging from 10 min to 7 hr. In other experiments, freshly isolated cells were used immediately after isolation and were incubated in suspension with the gold probes.
Four types of experiments were used to ver* the specificity of internalization of SP-A-gold. (a) We used alkylated rat SP-A as a negative control. Alkylation of SP-A is known to prevent binding of the protein to its receptor on alveolar Type I1 cells (14). (b) For competition experiments, excess native rat SPA (15 pglml) was added together with the gold-conjugated rat SP-A to the cultured cells. (c) We inhibited endocytosis by treatment with 0.45 M sucrose in DMEM-FBS for 5 min before and during exposure of Type I1 cells to the gold label for various lengths of time. Hypertonic treatment is known to inhibit receptor-mediated endocytosis via coated pits (30). (d) Excess rabbit anti-rat SP-A antibody was incubated with rat SP-A gold for 2 hr at 37°C before incubation with the cells.
Inhibition of Surfactant Lipid Seaetion by SPA-gold. The inhibition of phospholipid secretion from alveolar Type I1 cells by SP-A-gold conjugates was tested with methods described by Sano et al. (31) and Kuroki et al. (14.22) . Briefly, Type I1 cells were cultured for 21 hr with [3H]-choline in DMEM-FBS. Non-adherent cells and unbound radioactive precursors were removed and fresh medium was added together with the gold probes, native rat, recombinant rat, and human SP-A in either unconjugated or goldconjugated forms. 12-0-tetradecanoyl-phorbol-13-acetate ( P A lo-' M) was used to induce secretion for 3 hr at 37'C. Secretion was measured with
[3H]-phosphatidylcholine as a marker for surfactant and was expressed as percent secretion (radioactivity in mediumlradioactivity in medium plus cells).
The different SP-A-gold probes (8 and 15 nm) were added to the secretion medium at various concentrations (5-25 PI). Initial gold concentrations in all probe solutions were identical based on absorbance at 520 nm (A520m = 4.5). The stochiometry of the various SP-A molecules conjugated to the gold probes is unknown. Therefore, an attempt was made to quantify the amount of rat SP-A conjugated to 8-nm gold by using radiolabeled rat SP-A of known specific activity.
[ '2SI]-SP-A was prepared according to the method of Bolton and Hunter (32) as described previously (10) and was conjugated to 8-nm gold particles in a similar fashion to the nonradiolabeled SP-A. This radioactive gold probe was added to the secretion medium at a rat SP-A concentration of 1 pg/ml. BSA, which does not inhibit secretion, was used as a control after its conjugation with gold.
Electron Microscopy. Cells were fixed for 3 hr in 2% glutaraldehyde in 0.1 M Na-cacodylate buffer, pH 7.4, at room temperature. The cells were further fixed with osmium tetroxide and either treated with tannic acid and processed as described (33) or processed according to Williams (34). In both procedures the cells were dehydrated in cold acetone, scraped from the culture dishes in 95% acetone. sedimented in Eppendorf tubes, and embedded in Epon. Sections were counterstained with uranyl acetate and lead citrate and viewed with a Phillips 300 electron microscope.
Quantitative analysis of the gold-labeled structures (MVB and LB) at each internalization time point was performed by counting the labeled and unlabeled organelles within the cells under the microscope. Labeled (one or more gold particles) and unlabeled organelles were scored in at least 50 cells from two or more tissue blocks, and more than 100 organelles were counted at each time point. Results were expressed as a percent of organelles that were labeled with gold.
Immunoelectron Microscopy. Native SP-A in rat alveolar Type I1 cells was localized by the immunogold technique with affinity-purified rabbit anti-rat SP-A; the specificity of the antibody has already been described (14.22). Cells were fixed for immunolabeling for 1 hr in 2% glutaraldehyde-cacodylate buffer (0.1 M. pH 7.4) and then with osmium for 1 hr (1% osmium tetroxide), treated with uranyl acetate, and further processed according to Williams (34). A short treatment with osmium (1 hr instead of overnight as in the original method) was necessary for preservation of antigenicity of SP-A within the cells. Sections were treated with 0.2% Triton X-100-PBS for 20 min at 4'C before the immunolabeling. The immunogold procedure was then continued according to Varndell et al. (35) and Kalina et al. (36) . Anti-rat SP-A was used at concentrations of 8 pg/ml. Goat anti-rabbit IgG absorbed to 10-or 15-nm gold particles diluted 1:15 (Bio Cell; Redding, CA) was used as secondary antibody. After the immunogold labeling, sections were rinsed, contrasted with uranyl acetate and lead citrate, and viewed in the electron microscope. The density of immunogold labeling of LB was performed on electron micrographs enlarged x 45,000 as previously described (36.37). Briefly, the gold particles were counted and the cross-sectional area of the LB was estimated by using a morphometric grid.
Results
To test the effect of cell shape on endocytic processes, the alveolar Type I1 cells were grown on PDLcoated and uncoated plastic dishes. The cells cultured on plastic for 20-22 hr in DMEM-FBS appeared as flattened groups of cells. When they were cultured on PDL the flattening of the cells was delayed, and after 18 hr the cells still appeared rounded and some of the cells retained their microvilli (Figures 1 and 2) . Flattening of the cells cultured on PDLoccurred after 48 hr (data not shown). The cells under both culture condi- tions retained their cytoplasmic ultrastructural appearance, especially electron-lucent multivesicular bodies (MVB), electron-dense MVB (D-MVB) in which lamellar structures were associated with the vesicles within the organelle, and well-preserved LB (Figures 9, 10, 12, and 13). However, there were many more multicentric LB in cultured cells (flat and rounded) than in freshly isolated Type I1 cells (Figures 10 and 13 ). This is probably the result of fusion of several LB into multicentric LB.
Endocytosis of Lucifer Ellow into Alveolar Type 11 Cells
The dye Lucifer Yellow was used as a marker to test fluid-phase endocytosis by cells grown on PDL vs tissue culture plastic. Endocytosis of Lucifer Yellow by rounded cells (grown on PDL) and flat cells is shown in with punctate distribution throughout the cytoplasmic regions in the flat cells. The rate of accumulation of Lucifer Yellow in Type I1 cells (rounded and flattened) (Figure 4 ) was found to be three to four times higher in the round than the flat cells. Accumulation of the dye in both cells was initially rapid but after 60 min reached a slower steady-state rate that remained constant over the 3-hr experimental period. These results are similar to those described in macrophages by Swanson et al. (19) . The data presented in Figure  4 were standardized to DNA, and similar results were also obtained when they were standardized to total cell protein.
Internalization of Human SPA by Rut Type 11 Cells: Light Microscopy
Human SP-A was used to examine the internalization of a purified, unconjugated SP-A molecule by alveolar Type I1 cells. Human SP-A is known to bind to the receptor for SP-A on rat Type I1 cells and to inhibit the secretion of phospholipids (22). The SP-A was detected in the cells by use of a specific monoclonal antibody to human SP-A, which does not crossreact with the endogenous rat proteins. Accumulation of human SP-A in the rat Type I1 cells was a slow process, and after 7 hr of incubation only 10-20% of the cells grown on PDL contained immunocytochemically demonstrable SP-A. Cells grown on plastic and incubated with SP-A for the same time period were completely unstained (data not shown). The internalized SP-A was localized mainIy in peripheral large structures; however, some diffuse staining could also be seen in the cytoplasm ( Figure 5 ). The peripheral localization of the large structures may indicate the accumulation of SP-A within LB. This localization was different from the juxtanuclear localization of Lucifer Yellow (Figure 3a) . Such a localization of the dye was expected, as Lucifer Yellow was previously found not to enter LB (17,38). I1 cells (13-15). Therefore, the biological activity of the various gold probes was tested by their capacity to inhibit phospholipid secretion from isolated Type I1 cells. The results presented in Figure 6 demonstrate that all SP-A-gold probes tested (rat, human, and recombinant) inhibited TPA-induced phospholipid secretion, but the degree of inhibition achieved varied among the probes. The rat SP-A-gold conjugate inhibited secretion to a similar degree as non-conjugated native rat SP-A (1 pglml) used as a control. The concentration of gold-conjugated rat SP-A was then calibrated with ['2'I]-SP-A, in which 1 pglml of gold-conjugated [ 12'I]-SP-A (8-nm gold) was added based on the specific activity of the radiolabeled protein ( Figure 6 . Column 4). Inhibition with this gold probe was similar to that of native rat SP-A (1 pglml); (Figure 6 , Column 3). The amount of SP-A conjugated to the other gold probes is unknown; however, optical density of the gold conjugates (8-and 15-nm) was adjusted according to the [ 12SI]-SP-A-gold (OD520nm = 4.5). Signifcant inhibition was also observed with recombinant and human SP-A probes (8-and 15-nm gold). It should be emphasized that the actual concentrations of proteins in these gold probes were unknown. This inhibition was similar to that previously observed with unconjugated SP-A (data not shown). Recombinant SP-A is an effective inhibitor of secretion from Type I1 cells but is less potent than native rat SP-A (ODs0 0.5 vs 0.1, respectively) (23, 24) . The large gold conjugates (15 nm) were less effective than 8-nm gold and higher concentrations of gold conjugates were needed to achieve inhibition. This is probably due to a diminished interaction of SP-A with its receptor when the protein is conjugated with the larger gold particles. The BSA-gold probe (8 nm) was used as a control and did not inhibit secretion. We conclude that the goldconjugated SP-A probes (rat, human, and recombinant) retain their biological ability to inhibit secretion. Assuming that the SP-A functions to modulate surfactant lipid secretion and to become internalized are mediated through the same receptor, this assay validates their use as probes for specific internalization by Type I1 cells. 
Biologicul Activity of SPA-Gold Conjugates

Internalization of SPA-GoLd Probes
Alveolar Type I1 cells cultured on both PDL and plastic were used in the internalization experiments. Unless otherwise stated, the following results were obtained with PDL cultured cells. Three SP-A gold probes were used (rat, recombinant, and human), either singly or combined, using 8-or 15-nm gold particles for each SP-A species.
After internalization for 10-60 min. each of the SP-A-gold probes (rat, recombinant, and human) was found in coated vesicles and elements of the endosomal system: small vesicles, tubular structures, MVB, and DMVB (Figures 7 and 8) . At 1 hr of internalization approximately 40% of the MVB were labeled; however, only a small percent of gold labeling was detected in LB (<I%) ( Figure  11 ). Incubation of the cells for 3 hr with the gold probes resulted in an increase in the number of labeled MVB (70%), as well as labeled LB (20 3%) (Figures 9 and 11 ). Prolonged incubation with the gold probes (7 hr) did not alter the percentage of labeled MVB; however. the number of gold-labeled LB increased to 37 .c 5% (Figures 10 and 11) . and over 70% of the cells were labeled. Gold particles in LB were localized exclusively in the amorphous non-lamellar region of these organelles, mainly at the periphery. often in MVB structures associated with the LB (Figures 9, 10 . 12, and 13). Gold particles were confined only to the endosomal system and LB. No gold particles were observed in the Golgi apparatus. mitochondria, or the cell cytoplasm. Internalization of recombinant SP-A and human SP-A-gold conjugates to LB is shown in Figures 12 and 13 . In some experiments, native rat SP-A was incubated with the cells together with recombinant or human SP-A (gold particle sizes 8 and 15 nm. respectively). In these experiments, both gold particles were often co-localized in the same organelles (Figure 14) . No qualitative differences were observed among the three species of SP-A used in the present study. The percentage of labeled LB was also similar (30-40% labeling after 7 hr internalization) with the three probes (Figure 11) . The number of gold-labeled LB (range of 1-200 gold particles/LB) was used as an indicator for internalization. A high percentage of labeled LB was generally associated with large numbers of internalized total gold particles in MVB and LB, whereas cells with a low percentage of labeled LB contained very few gold particles. No mor- Figure 9 . A cell incubated with rat SP-A-gold (8 nm) for 3 hr; note the gold particles at the periphery of a LB (arrowheads), within DMVB (small arrow). and a large DMVB or growing LB (large arrow). phometric analysis, however, was performed owing to the difficulSeveral control experiments were conducted to test the specificties in relating the number of gold particles to the organelle volity of rat SP-A-gold internalization and are summarized in Table   ume . especially LB. It is therefore possible that internalization of 1. Alkylated rat SP-A, which does not bind to the cell receptor for recombinant and human SP-A differs quantitatively from that of SP-A. internalized poorly as compared with native rat SP-A. Addirat SP-A.
tion of excess native rat SP-A (15 vglml) in a competition assay re- from the peripheral rim (Figure 17 ). This distribution is in agreement with previous results obtained by employing a similar immunogold technique for ultra-thin cryosections (39,40). Gold particle density (23 particles/pn2) over LB appeared lower than that previously described for immunogold labeling of cryosections (160 particles/ pn2) (39); however, it was five-to sixfold higher than in the neighboring mitochondria, which were used as an internal control (4 particles/pn2).
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Discussion
The present work demonstrates uptake of SP-A (native rat SP-A, duced to a large extent the internalization of rat SP-A-gold. Addition of anti-rat SP-A antibody to rat SP-A-gold almost completely inhibited intemalization. Internalization of the gold label in the presence of 0.45 M sucrose also inhibited the internalization process. The latter treatment is known to inhibit receptor-mediated endocytosis via coated pits (30) and therefore suggests that internalization of SP-A-gold occurs via coated pits and is receptor mediated.
A comparison in gold-labeled SP-A internalization was made between freshly isolated cells and cells in primary culture and between the rounded cells grown on PDL and the flat cells on plastic. Freshly isolated Type I1 cells, incubated in suspension with the gold probes for lengths of time up to 4 hr, internalized very few gold particles (data not shown). Electron microscopic observations did not reveal any qualitative ultrastructural changes in organelles associated with the internalization process, MVB and LB (Figure 15) . Quantitative analysis of the percentage of gold-labeled LB, however, indicated a much slower rate of LB labeling by the flattened as compared with the rounded cells (Figure 16 ). The percentage of gold-labeled LB after internalization of rat SP-A-gold for 1 hr, 3 hr, and 7 hr indicates approximately O%, 5%, and 14% of labeled LB, respectively, as compared with 1%, 20%, and 30%, respectively, of labeled LB in cells grown on PDL.
Immzlnogold Localization of Endogenous Rat SPA
In view of the peripheral localization of internalized SP-A-gold probes in LB, we attempted to compare the localization of resident SP-A in the cells by using the immunogold technique. The aldehydefixed cells that were processed by modification of Williams' method (34) preserved the antigenicity of SP-A as well as the lamellar structure of the LBs. The immunogold label for SP-A was homogeneously distributed over the lamellae within the LE! but was excluded I ---r in receptor-mediated endocytic processes (41) (42) (43) . LB were also labeled with the gold probes; approximately 35% of the LB were labeled after 7 hr of internalization. No qualitative differences in intemalization or rate of LB labeling were observed among the three SP-A species used in the present study. The lack of hydroxyproline and the altered glycosylation of the recombinant SP-A did not qualitatively alter its internalization or the rate of LB labeling. This finding implies that alterations in the composition of the oligosaccharide and changes in the hydroxylation state of the collagen-like domain of the SP-A molecule do not disrupt binding and intercellular trafficking of SP-A.
The gold probes used in the present study were determined to be biologically active, as assessed by their ability to inhibit phospholipid secretion by Type I1 cells in vitro. Complete inhibition of secretion was obtained with gold-conjugated rat SP-A at the same concentration of non-conjugated SP-A that is known to inhibit phospholipid secretion to below basal levels (1 Nglml) (14,22) . This adds credibility to the use of gold-conjugated SP-A as a biologically valid probe. The specificity of SP-A-gold internalization was demonstrated by using excess non-conjugated SP-A as a competitor or goldconjugated alkylated SP-A. Both treatments resulted in the inhibition of internalization of SP-A-gold. Alkylation of SP-A modifies primary amines that are thought to be important in receptor binding phenomena. This treatment prevents receptor binding, lipid aggregation, and inhibition of secretion (14,15,22) . Internalization of SP-A-gold was also inhibited by hypertonic sucrose medium, which is known to block receptor-mediated endocytosis (30). Similar inhibition was previously observed with mixtures of gold-conjugated surfactant proteins (17).
Gold-conjugated SP-A appeared to be internalized via the endosomal system to LB. The labeling of LB was time dependent; after 1 hr, 3 hr, and 7 hr, <I%, 20%, and 35% of the LB were labeled, respectively. Ryan et al. (11) demonstrated binding and internalization of SP-A via coated vesicles and the endosomal system in isolated rat Type I1 cells in a similar fashion to the data presented in this study. However, unlike the present study, those authors were unable to detect any gold label in LB after 60 min of incubation. The discrepancy between the results could be interpreted in the relative slow labeling of the LB; only <I% of the LB in the present study were labeled after 60 min of incubating the cells with the gold probes. Ryan et al. (11) also used cells cultured on plastic and incubated at 23°C. instead of the 37% used in the present study, a factor that probably also contributed to a slower rate of intracelMar trafficking of SP-A to LB.
The accumulation of SP-A within alveolar Type I1 cells under in vitro conditions appears to be a slow process. Kuroki et al. (10) have shown that primary cultures of alveolar Type I1 cells (cell isolation and culture conditions similar to those described in the present study) express a high-affinity receptor for SP-A. Internalization of . . SP-A was not accompanied by degradation over 8 hr of observation. The lack of degradation and the potential reutilization of SP-A is similar to that observed for the transferrin receptor (44, 45) . The rates of accumulation of the ligand within cells in vitro appear to differ between SP-A and transferrin receptors, the latter being a much faster process. Accumulation of SP-A oligomers was measured in hours (10) as compared to that of iron ions, which was measured in minutes (45). It is important to note that the data presented by Kuroki et al. (10) as well as in the present study were obtained by in vitro study on cultured alveolar Type I1 cells. It is possible that in vivo rates of accumulation of SP-A within the alveolar Type I1 cells are significantly faster. Support for a faster rate of internali- The time-dependent internalization studies also indicated that after 7 hr only 30-40% of the LB were labeled. A similar percentage of LB labeling was also observed by Kalina and Socher (16) using gold-labeled whole rat native surfactant proteins. Two possible interpretations can be given to the observed partial LB labeling. (a) It is possible that only a subpopulation of the LB is involved in the processing of internalized SP-A. whereas other LB are associated with newly synthesized surfactant-associated proteins. Two subfractions of LB have been suggested by several investigators using various analytical techniques (7, 46, 47) . No proof, however, exists for a routing of internalized SP-A towards a specific LB subpopulation. (b) A systematic error in the estimated gold labeling in tissue sections may be present. Using a morphometric approach, Hamme1 and Kalina (48) estimated the size and gold density of goldlabeled regions in LB by a stereological approach. It was demonstrated that the low percentage of gold-labeled LB can be explained as a result of the probability of random sectioning through the distinct, small peripheral labeled areas. These authors, however, did not exclude the first possibility of internalizing SP-A into a specific subpopulation of LB.
The relatively rapid gold labeling of MVB (40% in 1 hr incubation) as compared to the labeling of LB (<I% in 1 hr) may be associated with a slow trafficking of SP-A-gold from the endosomal system to LB in our in vitro system. However, because of the exclusive regional localization of the gold label in the LB and the morphometric limitations discussed previously, such a notion cannot be proven in the present study. However, a support for a slow trafficking to LB within the Type I1 cells is indicated in the work of Fisher et al. (49) on alveolar uptake of radiolabeled lipids and protein components of surfactant. These authors observed after 2 hr of internalization that the microsomal fraction has a ratio of lipidlproteins similar to the original surfactant, whereas in the LB this ratio was increased 2.1-fold. which indicates a slow trafficking of the protein component to LB.
Recombinant SP-A produced in an insect cell expression system was found to be internalized and routed in a fashion that was indistinguishable from native human and rat SP-A. This protein diffen from the native molecules. The proline residues of the collagenlike region are not hydroxylated. The recombinant protein does not form high-order oligomers to the same extent as native SP-A, and the glycosylation of the protein is different, in that the recombinant is mannose rich and lacks sialic acid (23.24.50). However, the protein retains the lectin-like characteristics of the native molecule as it is purified with immobilized mannose. The recombinant SP-A effectively inhibits the secretion of phospholipids from Type I1 cells. The internalization of SP-A to lamellar bodies suggests that the structural differences of the recombinant proteins do not affect the receptor binding and intracellular trafficking of the molecule. Mutant proteins produced in this system may elucidate the structural determinants of SP-A required for internalization and intracellular trafficking. Localization of internalized gold label in LB was always restricted to the amorphous non-phospholipid regions of the organelle as was previously described (16). Such regions were mainly found at the periphery of LB. as well as in MVB associated with the LB. Similar localization in LB was also observed by Williams (51) after internalization of ferritin-labeled Maclu~upomife~u lectin. Endogenous SP-A was found, however, to be evenly distributed over the phospholipid regions. Such a distribution of SP-A in LB was previously demonstrated by Coalson et al. (52) . Walker et al. (39) . and Voorhout et al. (40) . The peripheral non-phospholipid-associated localization of the internalized SP-A-gold does not necessarily imply a separate localization within the LB. It is possible that the large gold particles prevent the distribution of the internalized SP-A and its intra-LB association with the phospholipids. However, the possibility of an internalized SP-A localization that is different from endogenous SP-A cannot be excluded.
It is well accepted that primary cultures of adult Type I1 cells maintained on tissue culture plastic rapidly lose both morphological and biochemical characteristics of functional differentiation (53,54). Within 24 hrofculture, cells lose most of the SP-A protein content and the mRNAs for SP-A, SP-B, and SP-C (55; and unpublished data) . Ultrastructurally, the most notable change in the cells in primary culture was an increase in the number of multicentric LB. The flattening of the cells on plastic and changes in the cytoarchitecture have been implicated as one of the potential reasons for the loss of differentiated function (56-58). In the present study an attempt was made to delay the flattening of the cells by growing them on PDL on which the cells maintained their cuboidal rounded appearance for at least 24 hr. Cells grown on PDL were found to better maintain both endocytic functions, fluid-phase and receptor-mediated endocytosis as compared with the flattened cells. Of interest is the observation that freshly isolated Type I1 cells almost completely lose the ability to endocytose SP-A-gold; this function was regained after 18 hr in culture. This may be due to the effect of the isolation procedure on the freshly isolated cells.
Internalization and recycling of surfactant phospholipids, as well as SP-A, have been well documented (3-7). Recently it was suggested that SP-C is also internalized into LB by Type I1 cells (59). Estimates of alveolar surfactant recycling in adult animals range from 25-85% (4,5,8). Young et al. (7) demonstrated uptake of radiolabeled SP-A by alveolar Type I1 cells after instillation into rat lung. The SP-A was found to accumulate with time in the LB fraction. The present data support the notion that SP-A is reutilized by internalization into LB. The cumulative data concerning SP-A internalization, as well as its effect in enhancement of liposomal phosphatidylcholine uptake and modulation of phospholipid secretion, support its role in maintaining surfactant homeostasis in the alveoli.
